Speech-Language Pathologists in Shenandoah Junction, WV Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Samuel Chambers, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Caspian Way, Shenandoah Junction, WV 25442 Phone: 304-885-5020 |
 Evolve Pediatric Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 164 Rawhide Ln, Shenandoah Junction, WV 25442 Phone: 304-582-5320 |
 Rachael Lorinn Spencer, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Shenandoah Junction Rd, Shenandoah Junction, WV 25442 Phone: 304-728-7250 |
Mrs. Tricia Anne Shumate, MS SPEECH LANGUAGE P Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Shenandoah Junction Road, Ta Lowery Elementary School, Shenandoah Junction, WV 25442 Phone: 304-728-7250 Fax: 304-728-7631 |
News Archive
Idera announces delay in commencement of IMO-2125 Phase 2 clinical trial in treatment-naive HCV patients
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Analysis stresses importance of multidisciplinary approach to cancer in the elderly
New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.
Depressed cardiac patients at added risk
Coronary artery disease patients may have an increased risk for peripheral arterial disease if they are depressed, study findings show.
Just one puff enough to start a habit later on
New research in the UK suggests that it takes just one cigarette as a child to create the adult habit which so many find hard to kick.
Wolverine Venture Fund participates in $8M series A round of financing for Delphinus Medical Technologies
The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.
› Verified 7 days ago